05/27/21 Akorn Announces Agreement to Sell its Consumer Health Business to Prestige Consumer Healthcare
05/10/21 Akorn Announces Two Key Executive Appointments
02/26/21 Akorn Announces Review of Strategic Alternatives for the Akorn Consumer Health Business
02/11/21 Akorn Receives FDA Approval for Loteprednol Etabonate Ophthalmic Gel, 0.5%
10/28/20 Akorn Announces Its New Board of Directors

Events Events

Date Title Download
No upcoming events scheduled. Please check back.

Annual Reports Media Contact

Please direct all media inquiries to